Anesthesiology Performance Improvement and Reporting Exchange (ASPIRE)
Quality Committee Meeting Notes Monday, November 25
th
, 2024
Attendance:
Abess, Alex (Dartmouth)
Lewandowski, Kristyn (Corewell)
Abou Nafeh, Nancy (AUB)
Lopacki, Kayla (Mercy Health - Muskegon)
Addo, Henrietta (MPOG)
Lozon, Tim (Henry Ford - Wyandotte)
Armstrong-Browder, Lavonda (Henry Ford)
Lu-Boettcher, Eva (Wisconsin)
Barrios, Nicole (MPOG)
Mathis, Mike (MPOG)
Berndt, Brad (Bronson)
Malenfant, Tiffany (MPOG)
Bollini, Mara (WUSTL)
McComb, Joseph (Temple U)
Bow, Peter (Michigan)
McKinney, Mary (Corewell Dearborn / Taylor)
Bowman-Young, Cathlin (ASA)
Milliken, Christopher (Sparrow)
Brennan, Alison (Maryland)
Mirizzi, Kam (MPOG)
Bryant, Ayesha (UAB)
O’Conor, Katie (Johns Hopkins)
Buehler, Kate (MPOG)
O’Dell, Diana (MPOG)
Calabio, Mei (MPOG)
Owens, Wendy (MyMichigan - Midland)
Cassidy, Ruth (MPOG)
Pace, Nathan (Utah)
Chopra, Ketan (Henry Ford - Detroit)
Pantis, Rebecca (MPOG)
Clark, David (MPOG)
Pardo, Nichole (Corewell)
Cohen, Bryan (Henry Ford - West Bloomfield)
Parks, Dale (UAB)
Coleman, Rob (MPOG)
Penningon, Bethany (WUSTL)
Collins, Kathleen (St. Mary Mercy)
PIlat, Marianne (Sparrow)
Colquhoun, Douglas (MPOG)
Pimentel, Marc Phillip (B&W)
Corpus, Charity (Corewell Royal Oak)
Poindexter, Amy (Holland)
Cuff, Germaine (NYU)
Roselinsky, Howard (Yale)
Denchev, Krassimir (St Joseph Oakland)
Rozek, Sandy (MPOG)
DePasquale, Will (NYU Langone)
Saffary, Roya (Stanford)
Dewhirst, Bill (Dartmouth)
Schwerin, Denise (Bronson)
Doney, Allison (MGH)
Scranton, Kathy (Trinity Health St. Mary’s)
Dutton, Richard (US Anes Partners)
Shah, Nirav (MPOG)
Elkhateb, Rania (UAMS)
Shettar, Shashank (OUHSC)
Esmail, Tariq (Toronto)
Smiatacz, Frances Guida (MPOG)
Everett, Lucy (MGH)
Spanakis, Spiro (UMass)
Finch, Kim (Henry Ford Detroit)
Stanislaus, Mellany (Johns Hopkins)
Gibbons, Miranda (Maryland)
Stierer, Tracey (Johns Hopkins)
Goatley, Jackie (Michigan)
Stewart, Alvin (UAMS)
Goldblatt, Josh (Henry Ford Allegiance)
Stumpf, Rachel (MPOG)
Hall, Meredith (Bronson Battle Creek)
Toonstra, Rachel (Corewell West & UMHS West)
Harwood, Tim (Wake Forest)
Tyler, Pam (Corewell Farmington Hills)
Heiter, Jerri (St. Joseph A2)
Vaughn, Shelley (MPOG)
Janda, Allison (MPOG)
Vitale, Katherine (Trinity Health)
Jewell, Elizabeth (MPOG)
Wade, Meredith (MPOG)
Johnson, Rebecca (Spectrum & UMHS West)
Wedeven, Chris (Holland)
Kaper, Jon (Corewell Trenton)
Weinberg, Aaron (Weill Cornell)
Khan, Meraj (Henry Ford)
Wissler, Richard (University of Rochester)
Kheterpal, Sachin (MPOG)
Yuan, Yuan (MPOG)
Kirke, Sarah (Nebraska)
Yoo, Ellie (NYU Langone)
LaGorio, John (Trinity Muskegon)
Zacharyasz, Katherine (Cleveland Clinic)
Liu, Linda (UCSF)
Zhu, Shu (Columbia)
Liwo, Amandiy (UAB)
Zittleman, Andrew (MPOG)
Agenda & Notes
Meeting Start: 10am
1. Agenda
2. Roll Call: Via Zoom or contact Coordinating Center (support@mpog.zendesk.com) if you were
present but not listed on Zoom.
3. Minutes from September 2024 Quality Committee Meeting
4. Announcements
1. Welcome Massachusetts Eye and Ear to MPOG!
2. Welcome University Health Network to MPOG!
3. Featured Member November and December
a. Jaime Hyman, MD Yale School of Medicine
5. 2024 Meetings
1. Friday, April 11, 2025 MSQC/ASPIRE Collaborative Meeting Novi, MI
2. Friday, July 18, 2025 ASPIRE Collaborative Meeting, Henry Executive Center Lansing,
MI
a. Will focus on regional anesthesia. Chris Wu, an anesthesiologist in New York,
will be our keynote and discuss the plan of care ultrasound.
3. Friday, September 2025 ACQR Retreat, Location TBD
4. Friday, October 10, 2025 MPOG Retreat, San Antonio, Texas
5. Upcoming Events
6. Disseminating Aggregate Multicenter Data
1. Aggregate Multicenter MPOG Reports Example Scenarios
a. QI Teams - figure displaying aggregate anonymized performance for a QI
measure as part of poster presentation
b. Quality Committee Our colleagues at ASA/AQI have requested permission to
use a screenshot of MPOG QI Reporting Tool anonymized performance
benchmarking graph
c. Recent Requests from Research Teams:
1. Table showing the # of times ketorolac was administered for pediatric
tonsillectomies at each anonymized MPOG site
2. Line graph showing monthly trend in % cases adherent to NMB-05 QI
metric (use of quantitative twitch monitoring) for all MPOG institutions
d. Please contact the CC before disseminating any results
e. Coordinating Center reviews all request and will either approve (i.e., expediting
review) or review at QC based on these 4 factors:
f. Discussion:
1. Tariq Esmail (UHN-Toronto): Is there a plan for a central repository
where our community can see where these things have been posted?
2. Nirav Shah (MPOG Quality Director): Great question. We have
discussed capturing non-peer-reviewed publications, newsletter
articles, and other types of press by creating a space on our website.
7. Pediatric Subcommittee Updates
1. Goal to build 2-3 specific metrics using a uniform peds cardiac cohort
a) In the process of refining Peds Cardiac Procedure phenotype.
b) Plan to review blinded data variation for measures of interest at next
meeting in early 2025 to inform measure build direction.
2. General Pediatrics Committee: PONV-04-Peds Measure Review
3. Proposed Modifications: will be voted upon release of the new 2025 PONV guidelines
a) Success criteria → 1 agent for low-risk patients (0 risk factors), and combination
therapy of two agents for higher risk (≥ 1 risk factor).
b) Opioid risk factor → Multiple doses of any opioid intraop/postop
c) Include Infants
d) Consider Hydrocortisone IV as an antiemetic
e) Add Anticholinesterase administration intraop as a risk factor
8. MPOG Application Suite Upgrade: Coming Soon!
1. Upgrade package will be sent to each site’s IT contact (if you do not know who this is for
your site, contact support@mpog.zendesk.com)
2. Sites Using Desktop Virtualization (e.g., Citrix): Your site’s IT team will upgrade the App
Suite
3. Users using the App Suite installed on their PC: Your site’s IT team will distribute the
installer to all individuals at their site after the database upgrade has been applied.
4. Release Notes will be posted on the MPOG website once upgrade is available in early
December.
9. Patient Blood Management Toolkit Released!
1. Blood Management for the OB Patient slide deck is now available on the MPOG Toolkit
page under ‘Patient Blood Management’
2. Will soon release an updated version of the existing transfusion toolkit for the Adult
Surgical population
3. Please customize and adapt the content to meet your needs.
4. Feedback is always welcome!
10. QI Reporting Tool Update
1. Removed individual provider access to specialty dashboards in MPOG QI Reporting Tool
a) Currently individual providers have access to a dashboard (My Measure Dashboard)
that includes measures that are in the monthly provider feedback emails
b) They previously may have had access to the cardiac, pediatric, and OB dashboards
filtered to their own cases. This access has since been removed.
c) These dashboards were originally intended for quality champions and subspecialty
practice leaders, not individual providers.
d) Obstetric, cardiac, and pediatric site champions that only had access to one of the
specialty dashboards (not full Quality Champion access), will also no longer have
access to the departmental view of the specialty dashboards.
e) A user must have full Quality Champion access to view any of the specialty
dashboards at this time.
f) In the future, Coordinating Center plans to add specific subspecialty measures to the
“My Measure Dashboard” for individual providers to view.
g) While overall usage of the QI Reporting Tool is somewhat low among individual
providers, this change in access may generate questions to quality champions, so
wanted to inform Quality Committee members.
h) Quality Champions may request full departmental access for their specialty
champions (peds, cardiac, OB) to allow them to view specialty dashboards in
addition to All Measure and Site Directed measure dashboards.
i. Coordinating Center will be releasing a new feature within the QIRT:
‘Activity log to allow Quality Champions to monitor dashboard usage and
ensure transparency.
2. QI Reporting Tool will be updated to make it easier to view data from a Health Equity
perspective in 2025. We asked for participation, and several of you have already shown
interest. If you cannot attend and want to get involved, please reach out directly
(nirshah@med.umich.edu).
11. 2025 Measure Review Plan: Busy schedule ahead however most of the assigned reviewers have
already confirmed that they can do the review in 2025. Will form an ad hoc group to review
sustainability measures. Interested participants are invited to attend.
12. Measure Updates
1. ABX-03-C: Antibiotic Redosing, Open Cardiac
a. Description: Percentage of adult patient undergoing an open cardiac procedure
with an antibiotic re-dose initiate within four hours after initial antibiotic
administration (cephalosporins only)
b. Three antibiotics excluded from this measure:
1. Ceftriaxone and Cefotetan are excluded due to extended half-lives
relative to other commonly used cephalosporins and therefore, re-
dosing is not recommended for a typical cardiac case (these cases are
excluded NOT flagged)
2. Cefoxitin is also excluded as it is not typically used for cardiac cases and
would require more frequent dosing (these cases are excluded NOT
flagged)
c. Additional Updates:
1. Updating to account for antibiotic infusions (will not require re-dose if
infusion is still running)
2. Also adding a 15-minute window for early dosing (re-dosed at 2 hours
and 45 minutes instead of 3 hours)
2. SUS-02: Global warming Footprint, Maintenance
a. Description: This measure analyzes the percentage of cases where carbon
dioxide equivalents (CO
2
eq) normalized by hour for cases receiving inhalational
anesthetic agents (desflurane, isoflurane, sevoflurane, or nitrous oxide) is less
than CO
2
eq of 2% sevoflurane at 2L FGF = 2.83 kg CO
2
/hr or the Total CO
2
eq is
less than 2.83 kg CO
2
for the maintenance period of anesthesia.
b. Updated the measure and code to allow MPOG to calculate Total FGF from
component FGFs. Significant score changes for 4 sites and they were notified.
c. Updated the measure to include conversion of Nitrous Inspired % to Nitrous
flow (L/min). Minimal score changes
d. Also updated SUS-03(GWF Induction) and SUS-06 (FGF Induction, Peds)
e. Fixed bug that temporarily improved everyone’s SUS-02 scores by about 30%
3. TRAN-01 and TRAN-02:
a. TRAN-01: Percentage of adult patients receiving a blood transfusion with
documented hemoglobin or hematocrit value prior to administration
b. TRAN-02: Percentage of adult patients with a post transfusion hemoglobin or
hematocrit value greater than or equal to 10 g/dL or 30%, as a proxy for
overtransfusion
c. The approved changes are:
1. Include cardiac cases (previously excluded), as both Quality Committe
and Cardiac Subcommittee members determined that these measures
apply to cardiac procedures
2. “Ignore” autologous blood transfusion, as it is common and acceptable
practice to administer these blood products regardless of hgb/hct
values
d. Scores for most sites increase modestly. However, several sites saw drops in
performance scores for both measures, based on site cardiac cases transfusion
practices.
4. TOC-02: Transfer of Care to PACU (Postop)
a. Added 15-minute window after Anesthesia End to assess for handoff
documentation
b. Previous Measure Time Period: PACU Start to Anesthesia End
c. Current Measure Time Period: PACU Start to 15 minutes after Anesthesia En
d. Minimal score changes
13. New Measures
1. AKI-02-C: Acute Kidney Injury, Cardiac
a. Description: Percentage of patients undergoing an open cardiac procedure with
more than 1.5x increase in baseline creatinine within postoperative days or the
baseline creatinine level increases by > 0.3 mg/dL within 48 hours
postoperatively.
b. Measure Time Period: Up to 7 days after Anesthesia End
c. Exclusions:
1. ASA 6 including Organ Procurement
2. Cases where a baseline creatinine is not available within 60 days
preoperatively
3. Cases where a creatinine lab is not available within 7 postoperative
days
4. Patients with more than one case in a 7-day period. The first case will be
excluded if a postop creatinine is not documented for that first case. For
example, a patient that has surgery twice in a 7-day period, the first
surgery is excluded if a creatinine is not drawn between cases
5. Patients with pre-existing renal (stage 4 or 5) failure based on BSA-
Indexed EGFR < 30 mL/min/1.7m^2 determined by Preop EGFR (most
recent) or MPOG Complication Acute Kidney Injury value code 2
6. Liver Transplants
7. Open cardiac procedures performed in conjunction with:
1. Procedures affecting the kidney, bladder, or ureter
1. Anesthesia CPT and Surgical CPT codes
d. Success:
1. The creatinine level does not go above 1.5x the baseline creatinine
within 7 days post-op.
2. The creatinine does not increase by > 0.3 mg/dL obtained within 48
hours after anesthesia end.
e. We will be increasing threshold to ~30% or make it an informational measure.
Threshold is on the agenda for next Cardiac Subcommittee meeting
2. ABX-04-C: Antibiotic Selection for Open Cardiac Procedures
a. Description: Percentage of adult patients undergoing open cardiac surgery with
the recommended antibiotic agents administered for surgical site infection
prophylaxis
b. Measure Time Period: 120 minutes prior to Anesthesia Start through Anesthesia
End
c. Exclusions:
1. Age < 18 years
2. ASA 6 including Organ Procurement
3. Patients already on scheduled antibiotics or had a documented infection
prior to surgery (determined by ABX Notes value code: 2)
4. Procedures:
1. Lung transplants, as defined by the Procedure Type: Lung
Transplant phenotype
2. Non-cardiac, Transcatheter/Endovascular, EP/Cath, and Other
Cardiac cases (as determined by Procedure Type: Cardiac value
codes: 0, 2, 3, 4)
d. Success: Documentation of appropriate antibiotics preoperatively or
intraoperatively
e. Acceptable Antibiotics:
1. Vancomycin + Cephalosporin
2. Vancomycin + Aminoglycosides
3. Cephalosporin Only
4. Note: Only doses administered via IV route (MPOG Concept ID: 2001)
will be considered
5. Cases will be assigned on of the following results:
1. v Passed - Vancomycin + Cephalosporin
2. Passed - Vancomycin + Aminoglycoside
3. Passed - Cephalosporin Only
4. Flagged - Non-standard antibiotic selection
5. Flagged - Prophylactic antibiotic administered (Not documented
in MAR)
6. Flagged - Antibiotic not ordered/indicated per surgeon
7. Flagged - Not administered for medical reasons
8. Excluded - Scheduled antibiotics/documented infection
3. ABX-05-C: Composite Measure: Antibiotic Compliance for Open Cardiac Procedures
a. Description:
b. Measure Time Period:
c. Exclusions:
d. Success:
e. Note: Only doses administered via IV route (MPOG Concept ID: 2001) will be
considered
f. Cases will be assigned one of the following results:
1. Passed - Antibiotic Prophylaxis Standards Met
2. Flagged - Timing, Re-dosing, & Section Not Met (ABX-02-C, ABX-03-C, &
ABX-04-C flagged)
3. Flagged - Timing & Selection Not Met (ABX-02-C & ABX-04-C flagged)
4. Flagged - Re-dosing & Selection Not Met (ABX-03-C & ABX-04-C flagged)
5. Flagged - Timing & Re-dosing (ABX-02-C & ABX-03-C flagged)
6. Flagged - Antibiotic not administered on time (ABX-02-C flagged)
7. Flagged - Antibiotics not appropriately re-dosed (ABX-03-C flagged)
8. Flagged - Non-standard antibiotic selection (ABX-04-C flagged)
9. Excluded - Scheduled antibiotics/documented infection
Next Steps:
4. Repository for Publications: Coordinating Center to create a central repository for
capturing non-peer-reviewed publications and newsletter types on the website.
5. Specialty Champion Access: Quality Champions may request full departmental access
for their specialty champions (peds, cardiac, OB) to allow them to view specialty
dashboards in addition to All Measure and Site Directed measure dashboards. (Specialty
dashboard only view no longer available.)
6. Sustainability measure review (2025): Coordinating Center to form an ad hoc group to
review sustainability measures
Meeting Adjourned: 10:54am
Next meeting: January 27
th
, 2025